Avalign has been acquired by Arlington Capital Partners, a Washington D.C. based private equity firm. We are extremely pleased to be partnering with Arlington Capital. Avalign is committed to improving patient outcomes by providing best-in-class medical devices through our industry leading end to end capabilities. We believe that Arlington Capital, which has deep expertise and an impressive track record in healthcare and precision machining, is the ideal partner to help us achieve our goals.
Jul 15, 2015